Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 37.3B | 45.2B | 42.9B | 44.0B |
Cost of revenue | 20.2B | 28.2B | 25.1B | 29.4B |
Gross profit | 17.1B | 17.0B | 17.8B | 14.5B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 2.2B | 2.5B | 2.2B | 2.0B |
Other operating expenses | 11.7B | 11.1B | 12.1B | 10.0B |
Operating income | 1.0B | 1.2B | 1.4B | 561.1M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 540.6M | 531.5M | 764.9M | 699.8M |
Other income expense | — | — | — | — |
Pretax income | 1.0B | 1.1B | 1.1B | 163.4M |
Tax provision | 278.7M | 250.6M | 274M | 55.4M |
Net income | 724.6M | 802.3M | 789.6M | 108M |
Basic EPS | — | 1.5 | 1.4 | 0.2 |
Diluted EPS | — | 1.5 | 1.4 | 0.2 |
Basic average shares | — | 553.3M | 552.2M | 540M |
Diluted average shares | — | 553.3M | 552.2M | 540M |
EBITDA | 2.3B | 2.2B | 2.4B | 1.5B |
Net income from continuing op. | — | — | — | — |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |